Latest Listings And Ipos News

Healthscope has paid all rent due through April 2026 for hospitals owned by HealthCo Healthcare & Wellness REIT, while alternative operators submit plans to take over hospital operations.

Cauldron Energy Limited has clarified that its recent share price jump is driven by easing geopolitical tensions and a buoyant uranium market, with no undisclosed material information influencing trading.

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

CVC Limited has addressed ASX concerns over a delayed Appendix 3Y filing related to director John Leaver’s interest change, attributing the delay to administrative oversight while affirming existing compliance policies.

Advanced Innergy Holdings Ltd has responded to ASX inquiries denying any media leak regarding its proposed $0.40 cash bid for Matrix Composites & Engineering, reaffirming its commitment to strict disclosure policies.

Bougainville Copper Limited’s shares have been suspended from the ASX due to a late report lodgement, stirring investor concerns about compliance and transparency.

AVITA Medical has lodged a new $200 million shelf registration with the SEC, renewing its capacity to issue various securities in the US market. While no immediate capital raising is planned, this move preserves the company’s financial agility for future growth opportunities.

Since its October 2025 ASX IPO, Temas Resources has made significant strides in commercialising its proprietary metallurgical technology and advancing its Québec mineral projects, supported by solid financial reserves.

Patagonia Lithium has reported robust 72-hour pump test results from its Formentera lithium brine project, signalling promising aquifer connectivity and flow rates that support upcoming production targets.

Latitude Group Holdings has lodged a replacement prospectus for its Capital Notes 2 offer, revealing an increased offer size and updated margin following a completed bookbuild.

Pro Medicus Limited has announced an on-market buy-back program targeting up to 10% of its ordinary shares, aiming to return capital to shareholders without requiring approval.

Galan Lithium has finished Phase 1 construction at its Hombre Muerto West project in Argentina and is set to begin lithium production in the first half of 2026, marking a key milestone toward becoming an ASX-listed producer.